This studys findings suggest an association between semaglutide and NAION, the doctors wrote in their paper, published Wednesday in the journal JAMA Ophthalmology
Samples were permeabilized, blocked (Dako, #X0909) and then incubated with rabbit anti-glucagon (Santa Cruz, 1:200 discontinued) and mouse anti-GLP-1 (736) amide (Abcam #ab26278, 1:200) antibodies
Sigma-Aldrich, Steinheim, Germany) stimulation for 69.5 h at 37C and 5% CO 2 , followed by incubation with Alamar Blue (AbD Serotec, Oxford, UK) in a ratio of 1:10 for 2.5 h
We can monitor changes throughout your program rather than reacting to them after the fact
In 2014, OPM issued Carrier Letter 2014-04 clarifying that it is not permissible for FEHB plans to exclude weight loss drugs from FEHB coverage on the basis that obesity is a lifestyle condition and not a medical one or that obesity treatment is cosmetic. In 2019, OPM reminded carriers of their obligation to cover intensive behavioral therapy (IBT) for obesity management if referred as the result of a preventive screening
Not necessarily, but reducing intake during the titration period may make the first few months more comfortable, since alcohol and GLP-1 titration both cause nausea